Skip to main content
. 2020 Jul 22;8:e9409. doi: 10.7717/peerj.9409

Table 2. Frequency (n (%)) of antimicrobial use by health professional, syndrome and antimicrobial.

WAA NTA QLDA Total
Health professional Doctors 130 (53%) 51 (26%) 166 (72%) 347 (52%)
Nurses 100 (41%) 142 (72%) 63 (28%) 305 (46%)
A&TSIB health practitioner 1 (<1%) 3 (2%) 0 (0%) 4 (1%)
Unknown 12 (5%) 0 (0%) 0 (0%) 12 (2%)
Total 243 (100%) 196 (100%) 229 (100%) 668 (100%)
SyndromeC SSTI 86 (35%) 57 (29%) 92 (40%) 235 (35%)
GI 28 (12%) 19 (10%) 19 (8%) 66 (10%)
STI 24 (10%) 6 (3%) 28 (12%) 58 (9%)
LRTI 20 (8%) 35 (18%) 8 (4%) 63 (9%)
RHD 6 (2%) 22 (11%) 14 (6%) 42 (6%)
OtherD 79 (33%) 57 (29%) 68 (30%) 204 (31%)
Total 243 (100%) 196 (100%) 229 (100%) 668 (100%)
Antimicrobial Benzathine benzylpenicillin 37 (15%) 44 (22%) 31 (14%) 112 (17%)
Amoxicillin 27 (11%) 27 (14%) 24 (10%) 78 (12%)
Co-trimoxazole 16 (7%) 10 (5%) 42 (18%) 68 (10%)
OtherD 163 (67%) 115 (59%) 132 (58%) 410 (61%)
Total 243 (100%) 196 (100%) 229 (100%) 668 (100%)

Notes:

A

WA, Kimberley region of Western Australia; NT, Top End of the Northern Territory; QLD, far north Queensland.

B

A&TSI, Aboriginal and Torres Strait Islander.

C

SSTI, skin and soft tissue infection; GI, gastrointestinal infection; STI, sexually transmitted infection; LRTI, lower respiratory tract infection; RHD, rheumatic heart disease.

D

Other, all syndromes/antimicrobials with frequency <10% in every jurisdiction.